InflaRx NV (IFRX)
2.335
-0.16
(-6.60%)
USD |
NASDAQ |
May 19, 15:19
InflaRx EPS Diluted (Quarterly) : -0.0905 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Liminatus Pharma, Inc. | -0.0312 |
| Oruka Therapeutics, Inc. | -0.5767 |
| MapLight Therapeutics, Inc. | -1.342 |
| Kailera Therapeutics, Inc. | -- |
| QIAGEN NV | 0.3257 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.543M |
| Total Expenses (Quarterly) | 6.543M |
| Enterprise Value | 323.32M |
| Earnings Yield | -29.18% |
| Normalized Earnings Yield | -28.07 |